Juan Pablo Espinosa Leon

Juan Pablo Espinosa Leon

Auto-generated profile, based on publicly available information

Juan Pablo Espinosa Leon

Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in BJA Open
Verified
Journal Article
Open access
BOBrian O'GAra
Brian O'GAra
JLJuan Pablo Espinosa Leon
Juan Pablo Espinosa Leon
KRKortney Robinson
Kortney Robinson
MSMaximilian Sebastian Schaefer
Maximilian Sebastian Schaefer
DTDaniel Talmor
Daniel Talmor
MFMichael Fischer
Michael Fischer
Postoperative depression is not well characterised. We investigated the incidence of postoperative depression with the hypothesis that after controlling for confounders, new onset depression would vary significantly by surgical type. We conducted a retrospective cohort study using the Optum Clinformatics Datamart. The primary outcome was new onset postoperative depression, defined by a new diagnosis of depression or new prescription for an antidepressant in the year after surgery using International Classification of Diseases (ICD) 9/10 codes and drug names. Adjustment for preoperative comorbidities and predictors of depression was with multivariable Cox regression and propensity score matching. Sensitivity analyses defining new onset depression as both a new diagnosis of depression and a new prescription for an antidepressant, or either outcome separately, were conducted. Data from 132 390 cardiac surgery, 12 538 thoracotomy, 32 630 video-assisted thoracoscopic surgery (VATS), 96 750 hip fracture surgery, 157 484 hip replacement, and 347 878 laparoscopic cholecystectomy patients from January 2004 to June 2021 were analysed. The incidence of new onset postoperative depression was 18.8% for hip fracture surgery, 16.1% for thoracotomy, 12.6% for cardiac surgery, 12.4% for VATS, 8.6% for laparoscopic cholecystectomy, and 6.8% for hip replacement. After multivariable adjustment, hip fracture surgery patients were most likely to develop new onset postoperative depression (hazard ratio [95% confidence interval]) 1.56 [1.45–1.68]), followed by thoracotomy (1.12 [1.03–1.22]), cardiac surgery (1.09 [1.04–1.12]), VATS (0.95 [0.90–1.00]), and hip replacement (0.55 [0.52–0.57]) compared with patients undergoing laparoscopic cholecystectomy (hazard ratio=1). Results from propensity score matched analyses and sensitivity analyses were similar. The risk of postoperative depression differs by surgical type after controlling for preoperative characteristics.

16 January 2023 in Digestive Diseases
Verified
Journal Article
Open access
PDF file
FSFernando Sierra-Arango
Fernando Sierra-Arango
JHJose De la Hoz-Valle
Jose De la Hoz-Valle
JEJuan Pablo Espinosa
Juan Pablo Espinosa
JMJosé Moreno-Montoya
José Moreno-Montoya
MRMariana Vásquez Roldan
Mariana Vásquez Roldan
EPErika D. Pérez-Riveros
Erika D. Pérez-Riveros
Background: Topical treatments and botulinum toxin injections are valid options for the management of patients with chronic anal fissures (CAF) but little is known about the efficacy in a long-term follow-up. The aim of this meta-analysis was evaluate the effectiveness, given to clinical outcomes of medical treatments in adults. Method: this manuscript was developed according to PRISMA [23, 25] and registered in PROSPERO (Registration number: CRD42020120386). A systematic literature search was conducted through MEDLINE, EMBASE, Web of Science, and Cochrane Library databases. Randomized control trials that compared medical treatment were identified; publications had to have a clinical definition of CAF with at least one of the following signs or symptoms: visible sphincter fibers at the base of the fissure, anal papillae, sentinel piles, and indurated margins. The symptoms had to be chronic for at least 4 weeks. Results: 17 randomized trials met the inclusion criteria. Diltiazem showed a superior effect compared with glycerin (RR = 1.16 [95% CI = 1.05-1.30]; I2 = 18%), and with fewer adverse effects (RR = 0.13 [95% CI = 0 , 04-0.042]; I2 = 87%). Similar results were evidenced with the use of nifedipine compared with lidocaine (RR = 4.53 [95% CI = 2.99-6.86]; I2 = 28%). Botulinum toxin did not show statistically significant differences compared to glycerin (RR = 0.81 [95% CI = 0.02-29.36]; I2 = 93%) or isosorbide dinitrate (RR = 1.45 [CI 95% = 0.32-6.54]; I2 = 85%). Regarding recurrence, nifedipine was superior to lidocain (RR = 0.18 [95% CI = 0.08-0.44]; I2 = 31%). Conclusions: Calcium channel blockers performed well regarding the healing of CAF when compared to others in long-term follow-up. The superiority of botulinum toxin was not evidenced compared to topical treatments. More studies are needed to better assess recurrence rates.